Nevro Corp.

    Jurisdiction
    United States
    LEI
    254900SH91I4BOYKUE38
    ISIN
    US64157F1030 (NVRO)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    2 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. Read full profile

    Fundamentals

    Net revenue
    €348.45M
    Gross margin
    65.0%
    EBIT
    -€104.71M
    EBIT margin
    -30.0%
    Net income
    -€96.76M
    Net margin
    -27.8%

    Statement period: - (published )

    Products

    Product Revenue
    Reportable Segment €408.52M 117.2%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 1.2M $7.06M +909K Buy

    Earnings Calls

    Latest earnings call: May 7, 2024 (Q1 2024)

    Add to watchlist

    Notifications